Number of participants with adverse events leading to study discontinuation · Lennox‐Gastaut syndrome, any age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Seizure freedom · Lennox‐Gastaut syndrome, any age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
ADEs ( · adults
It is very uncertain whether CPOE/CDSS changes ADEs ( compared with control/paper‐based (very low certainty).
1 finding from 1 review
Mortality during hospitalisation ( · adults
It is very uncertain whether CPOE/CDSS changes mortality during hospitalisation ( compared with control/paper‐based (very low certainty).
1 finding from 1 review
Length of stay · adults
1 finding from 1 review
ADEs ( · adults
Improved CPOE/CDSS probably leads to lower ADEs ( compared with standard CPOE/CDSS (moderate certainty).
1 finding from 1 review
OR 0.82 [0.71, 0.94]
2382 participants
Moderate
Resolved potential ADEs (per prescriptions) ( · adults
1 finding from 1 review
no estimate extracted
1 participants
Low
Epworth Sleepiness Scale (ESS), week 3№ of participants: 101(2 RCTs) · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
High
Total nocturnal sleep time (minutes) · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Difficulty waking in the morning, average of weeks 1 and 2№ of participants: 10(1 RCT) · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Psychomotor vigilance task (PVT) reciprocal of reaction time, change from baseline№ of participants: 10(1 RCT) · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Quality of life Functional Outcomes of Sleep Questionnaire · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Number of participants with any adverse events№ of participants: 10(1 RCT) · idiopathic hypersomnia
Clarithromycin showed no clear difference in number of participants with any adverse events№ of participants:… compared with placebo (low certainty).
1 finding from 1 review
OR 0.41 [0.01, 12.64]
Studies not reported
Low
Number of naps/week, week 3№ of participants: 99(2 RCTs) · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Clinical Global Impression ‐ Severity (CGI‐S), change from baseline№ of participants: 30(1 RCT) · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Clinical Global Impression ‐ Change (CGI‐C), proportion much improved or very much improved at week 3 № of participants: 70 (1 RCT) · idiopathic hypersomnia
Modafinil probably leads to higher clinical Global Impression ‐ Change (CGI‐C), proportion much… compared with placebo (moderate certainty).
1 finding from 1 review
OR 5.14 [1.76, 15]
Studies not reported
Moderate
improvement in the maintenance of wakefulness test · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
High
Effectiveness · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Number of participants with any adverse events№ of participants: 102(2 RCTs) · idiopathic hypersomnia
Modafinil showed no clear difference in number of participants with any adverse events№ of participants:… compared with placebo (low certainty).
1 finding from 1 review
OR 1.68 [0.28, 9.94]
Studies not reported
Low
Daytime sleepiness (ESS): change from baseline. · idiopathic hypersomnia
1 finding from 1 review
no estimate extracted
Studies not reported
Low